News | November 11, 2024
Zydus Wellness Q2 FY25 sales up 12% at Rs. 490.7 Cr
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
Net profit for the quarter grew by 254.2 per cent and stood at Rs. 20.9 crore
For Q2, Akums reported a consolidated total income of Rs. 1,046.6 crore
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies
Extension of long-term collaboration includes construction of new customer-dedicated bioconjugation capacity in Visp (CH) and commercial antibody supply of a new ADC
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
The new facility uses the latest mammalian systems and single-use technology, including a production line with eight 2,000 L bioreactors
We now rank 3rd in pharmaceutical production by volume and 14th by value
Strategic focus on COCO-model with a nationwide reach of 501 stores
Cetirizine is used for relief of symptoms of hay fever and other allergic conditions
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
Subscribe To Our Newsletter & Stay Updated
